These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16683063)

  • 61. Rapid onset of action of levetiracetam in refractory epilepsy patients.
    French J; Arrigo C
    Epilepsia; 2005 Feb; 46(2):324-6. PubMed ID: 15679515
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study.
    Labate A; Colosimo E; Gambardella A; Leggio U; Ambrosio R; Quattrone A
    Seizure; 2006 Apr; 15(3):214-8. PubMed ID: 16420982
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Levetiracetam for phasic spasticity in multiple sclerosis.
    Hawker K; Frohman E; Racke M
    Arch Neurol; 2003 Dec; 60(12):1772-4. PubMed ID: 14676055
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Disfluent speech in patients with partial epilepsy: beneficial effect of levetiracetam.
    Sechi G; Cocco GA; D'Onofrio M; Deriu MG; Rosati G
    Epilepsy Behav; 2006 Nov; 9(3):521-3. PubMed ID: 16971185
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder.
    Post RM; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Leverich GS; Kupka R; Nolen WA; Luckenbaugh DA; Walden J; Grunze H
    J Clin Psychiatry; 2005 Mar; 66(3):370-4. PubMed ID: 15766304
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Open Label Trial of Add on Lacosamide Versus High Dose Levetiracetam Monotherapy in Patients With Breakthrough Seizures.
    Lee JW; Alam J; Llewellyn N; Hurwitz S; Bubrick EB; Sarkis RA; Weisholtz D; Yu H; Putta S; Dworetzky BA; Pennell PB
    Clin Neuropharmacol; 2016; 39(3):128-31. PubMed ID: 26992155
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Levetiracetam monotherapy for newly diagnosed epilepsy patients.
    Alsaadi TM; Thieman C
    Seizure; 2003 Apr; 12(3):154-6. PubMed ID: 12651080
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Levetiracetam monotherapy for elderly patients with epilepsy.
    Alsaadi TM; Koopmans S; Apperson M; Farias S
    Seizure; 2004 Jan; 13(1):58-60. PubMed ID: 14741184
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.
    Zhou B; Zhang Q; Tian L; Xiao J; Stefan H; Zhou D
    Epilepsy Behav; 2008 Feb; 12(2):305-10. PubMed ID: 18024209
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases.
    Kovács T; Farsang M; Vitaszil E; Barsi P; Györke T; Szirmai I; Kamondi A
    J Neural Transm (Vienna); 2009 Dec; 116(12):1631-4. PubMed ID: 19756367
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nonconvulsive status epilepticus on treatment with levetiracetam.
    Atefy R; Tettenborn B
    Epilepsy Behav; 2005 Jun; 6(4):613-6. PubMed ID: 15876554
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed-flexible dose study.
    Papp LA
    J Clin Psychiatry; 2006 Oct; 67(10):1573-6. PubMed ID: 17107249
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial.
    Muñana KR; Thomas WB; Inzana KD; Nettifee-Osborne JA; McLucas KJ; Olby NJ; Mariani CJ; Early PJ
    J Vet Intern Med; 2012; 26(2):341-8. PubMed ID: 22295869
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The acute effects of levetiracetam on nocturnal sleep and daytime sleepiness in patients with partial epilepsy.
    Zhou JY; Tang XD; Huang LL; Zhong ZQ; Lei F; Zhou D
    J Clin Neurosci; 2012 Jul; 19(7):956-60. PubMed ID: 22595355
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The efficacy of levetiracetam for patients with supratentorial brain tumors.
    Yuan Y; Peizhi Z; Maling G; Wu L; Yunhe M; Xiang W; Qing M; Yanhui L; Ruofei L; Jiewen L
    J Clin Neurosci; 2015 Aug; 22(8):1227-31. PubMed ID: 26051171
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Levetiracetam monotherapy for late poststroke seizures in the elderly.
    Kutlu G; Gomceli YB; Unal Y; Inan LE
    Epilepsy Behav; 2008 Oct; 13(3):542-4. PubMed ID: 18539085
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study.
    López-Góngora M; Martínez-Domeño A; García C; Escartín A
    Epileptic Disord; 2008 Dec; 10(4):297-305. PubMed ID: 19017572
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The treatment of neonatal seizures: focus on Levetiracetam.
    Loiacono G; Masci M; Zaccara G; Verrotti A
    J Matern Fetal Neonatal Med; 2016; 29(1):69-74. PubMed ID: 25385270
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effectiveness of levetiracetam in the treatment of lumbar radiculopathy: an open-label prospective cohort study.
    Hamza MS; Anderson DG; Snyder JW; Deschner S; Cifu DX
    PM R; 2009 Apr; 1(4):335-9. PubMed ID: 19627916
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam.
    Yates SL; Fakhoury T; Liang W; Eckhardt K; Borghs S; D'Souza J
    Epilepsy Behav; 2015 Nov; 52(Pt A):165-8. PubMed ID: 26432008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.